CS logo
small CS logo
Instituto do Cancer do Ceara - ICC

Fortaleza, Brazil
Hospital em Fortaleza, Ceará

About Instituto do Cancer do Ceara - ICC


"Somos, há 21 anos, a referência em tratamento oncológico no Norte-Nordeste. No nosso histórico, trazemos a visão centrada no paciente, o atendimento integral e uma Linha de Cuidado exclusiva como a expressão do nosso compromisso de entregar sempre as melhores soluções em saúde para os nossos clientes. Na trilha do Hospital do Câncer, crescemos como Hospital Haroldo Juaçaba e continuamos nossa história ampliando nossas frentes de operação e oferecendo ao público mais de 30 especialidades clínicas e gerais."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Instituto do Cancer do Ceara - ICC


During the past decade, Instituto do Cancer do Ceara - ICC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122111133224400000000001122Started TrialsCompleted Trails20162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Compassionate Use Trial for Unresectable Melanoma With Ipilimumab
No longer available
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
2016-06-01
2023-12-31
Active, not recruiting
290
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
2017-03-01
2022-09-16
Completed
349
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
2017-07-12
2029-06-24
Active, not recruiting
5,637
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
2018-12-18
2022-10-19
Terminated
623

Rows per page:

1–18 of 18

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto do Cancer do Ceara - ICC" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Clovis Oncology, Inc." with 2 trials sponsored, "Telik" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto do Cancer do Ceara - ICC" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "Foundation Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 3Eli Lilly and Company: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Clovis Oncology, Inc.: 2Clovis Oncology, Inc.: 2Telik: 2Telik: 2Bayer: 1Bayer: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Latin AmericanCooperative OncologyGroup: 1Latin AmericanCooperative OncologyGroup: 1Morphotek: 1Morphotek: 1Nektar Therapeutics: 1Nektar Therapeutics: 1

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 1AstraZeneca: 1BeiGene, Ltd.: 1BeiGene, Ltd.: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Eisai Europe Ltd.(United Kingdom): 1Eisai Europe Ltd.(United Kingdom): 1Foundation Medicine: 1Foundation Medicine: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1Pharmacyclics LLC.: 1Pharmacyclics LLC.: 1

Clinical Trials Conditions at Instituto do Cancer do Ceara - ICC


According to Clinical.Site data, the most researched conditions in "Instituto do Cancer do Ceara - ICC" are "Ovarian Cancer" (3 trials), "Epithelial Ovarian Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "Peritoneal Cancer" (2 trials). Many other conditions were trialed in "Instituto do Cancer do Ceara - ICC" in a lesser frequency.

Clinical Trials Intervention Types at Instituto do Cancer do Ceara - ICC


Most popular intervention types in "Instituto do Cancer do Ceara - ICC" are "Drug" (18 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (2 trials), "Lenalidomide" (2 trials), "Rucaparib" (2 trials), "5-Fluorouracil" (1 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto do Cancer do Ceara - ICC


The vast majority of trials in "Instituto do Cancer do Ceara - ICC" are 11 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Clinical Trials Status at Instituto do Cancer do Ceara - ICC


Currently, there are NaN active trials in "Instituto do Cancer do Ceara - ICC". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Instituto do Cancer do Ceara - ICC, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto do Cancer do Ceara - ICC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusRecruiting: 9Recruiting: 9Completed: 3Completed: 3Active, not recruiting: 2Active, not recruiting: 2Terminated: 2Terminated: 2Enrolling by invitation: 1Enrolling by invitation: 1No longer available: 1No longer available: 1